Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.15 billion. The enterprise value is $1.79 billion.
| Market Cap | 1.15B |
| Enterprise Value | 1.79B |
Important Dates
The last earnings date was Monday, March 2, 2026, before market open.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 48.89 million shares outstanding. The number of shares has increased by 2.91% in one year.
| Current Share Class | 48.89M |
| Shares Outstanding | 48.89M |
| Shares Change (YoY) | +2.91% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 10.97% |
| Owned by Institutions (%) | 59.85% |
| Float | 43.51M |
Valuation Ratios
The trailing PE ratio is 51.16 and the forward PE ratio is 18.19. Astrana Health's PEG ratio is 0.24.
| PE Ratio | 51.16 |
| Forward PE | 18.19 |
| PS Ratio | 0.36 |
| Forward PS | 0.29 |
| PB Ratio | 1.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.97 |
| P/OCF Ratio | 10.00 |
| PEG Ratio | 0.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.44, with an EV/FCF ratio of 17.17.
| EV / Earnings | 79.80 |
| EV / Sales | 0.56 |
| EV / EBITDA | 14.44 |
| EV / EBIT | 22.85 |
| EV / FCF | 17.17 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.93.
| Current Ratio | 1.40 |
| Quick Ratio | 1.35 |
| Debt / Equity | 1.93 |
| Debt / EBITDA | 7.69 |
| Debt / FCF | 10.32 |
| Interest Coverage | 1.57 |
Financial Efficiency
Return on equity (ROE) is 4.49% and return on invested capital (ROIC) is 4.00%.
| Return on Equity (ROE) | 4.49% |
| Return on Assets (ROA) | 2.75% |
| Return on Invested Capital (ROIC) | 4.00% |
| Return on Capital Employed (ROCE) | 4.90% |
| Weighted Average Cost of Capital (WACC) | 6.10% |
| Revenue Per Employee | $1.67M |
| Profits Per Employee | $11,835 |
| Employee Count | 1,900 |
| Asset Turnover | 1.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $15.53 million in taxes.
| Income Tax | 15.53M |
| Effective Tax Rate | 39.21% |
Stock Price Statistics
The stock price has decreased by -20.22% in the last 52 weeks. The beta is 0.90, so Astrana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -20.22% |
| 50-Day Moving Average | 23.62 |
| 200-Day Moving Average | 25.83 |
| Relative Strength Index (RSI) | 53.01 |
| Average Volume (20 Days) | 573,511 |
Short Selling Information
The latest short interest is 2.84 million, so 5.81% of the outstanding shares have been sold short.
| Short Interest | 2.84M |
| Short Previous Month | 2.56M |
| Short % of Shares Out | 5.81% |
| Short % of Float | 6.52% |
| Short Ratio (days to cover) | 4.79 |
Income Statement
In the last 12 months, Astrana Health had revenue of $3.18 billion and earned $22.49 million in profits. Earnings per share was $0.46.
| Revenue | 3.18B |
| Gross Profit | 341.53M |
| Operating Income | 78.53M |
| Pretax Income | 39.61M |
| Net Income | 22.49M |
| EBITDA | 124.27M |
| EBIT | 78.53M |
| Earnings Per Share (EPS) | $0.46 |
Balance Sheet
The company has $429.47 million in cash and $1.08 billion in debt, with a net cash position of -$648.66 million or -$13.27 per share.
| Cash & Cash Equivalents | 429.47M |
| Total Debt | 1.08B |
| Net Cash | -648.66M |
| Net Cash Per Share | -$13.27 |
| Equity (Book Value) | 558.33M |
| Book Value Per Share | 15.94 |
| Working Capital | 248.04M |
Cash Flow
In the last 12 months, operating cash flow was $114.60 million and capital expenditures -$10.11 million, giving a free cash flow of $104.49 million.
| Operating Cash Flow | 114.60M |
| Capital Expenditures | -10.11M |
| Free Cash Flow | 104.49M |
| FCF Per Share | $2.14 |
Margins
Gross margin is 10.73%, with operating and profit margins of 2.47% and 0.71%.
| Gross Margin | 10.73% |
| Operating Margin | 2.47% |
| Pretax Margin | 1.24% |
| Profit Margin | 0.71% |
| EBITDA Margin | 3.91% |
| EBIT Margin | 2.47% |
| FCF Margin | 3.28% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.91% |
| Shareholder Yield | -2.91% |
| Earnings Yield | 1.96% |
| FCF Yield | 9.12% |
Analyst Forecast
The average price target for Astrana Health is $35.33, which is 50.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.33 |
| Price Target Difference | 50.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 9.88% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 2.4 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.4 |
| Piotroski F-Score | 5 |